Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
A micromethod for quantitation of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography
|
Autores: |
Pereira,V.A.
Auler Jr.,J.O.
Carmona,M.J.
Mateus,F.H.
Lanchote,V.L.
Breimer,D.D.
Santos,S.R.C.J.
|
Data: |
2000-05-01
|
Ano: |
2000
|
Palavras-chave: |
Debrisoquine
4-hydroxydebrisoquine
HPLC-F
Urinary excretion kinetics
Debrisoquine test validation
CYP2D6
|
Resumo: |
We describe a new simple, selective and sensitive micromethod based on HPLC and fluorescence detection to measure debrisoquine (D) and 4-hydroxydebrisoquine (4-OHD) in urine for the investigation of xenobiotic metabolism by debrisoquine hydroxylase (CYP2D6). Four hundred µl of urine was required for the analysis of D and 4-OHD. Peaks were eluted at 8.3 min (4-OHD), 14.0 min (D) and 16.6 min for the internal standard, metoprolol (20 µg/ml). The 5-µm CN-reverse-phase column (Shimpack, 250 x 4.6 mm) was eluted with a mobile phase consisting of 0.25 M acetate buffer, pH 5.0, and acetonitrile (9:1, v/v) at 0.7 ml/min with detection at lexcitation = 210 nm and lemission = 290 nm. The method, validated on the basis of measurements of spiked urine, presented 3 ng/ml (D) and 6 ng/ml (4-OHD) sensitivity, 390-6240 ng/ml (D) and 750-12000 ng/ml (4-OHD) linearity, and 5.7/8.2% (D) and 5.3/8.2% (4-OHD) intra/interassay precision. The method was validated using urine of a healthy Caucasian volunteer who received one 10-mg tablet of Declinax®, po, in the morning after an overnight fast. Urine samples (diuresis of 4 or 6 h) were collected from zero to 24 h. The urinary excretion of D and 4-OHD, Fel (0-24 h), i.e., fraction of dose administered and excreted into urine, was 6.4% and 31.9%, respectively. The hydroxylation capacity index reported as metabolic ratio was 0.18 (D/4-OHD) for the person investigated and can be compared to reference limits of >12.5 for poor metabolizers (PM) and <12.5 for extensive metabolizers (EM). In parallel, the recovery ratio (RR), another hydroxylation capacity index, was 0.85 (4-OHD: SD + 4-OHD) versus reference limits of RR <0.12 for PM and RR >0.12 for EM. The healthy volunteer was considered to be an extensive metabolizer on the basis of the debrisoquine test.
|
Tipo: |
Info:eu-repo/semantics/other
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2000000500004
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/S0100-879X2000000500004
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.33 n.5 2000
|
Direitos: |
info:eu-repo/semantics/openAccess
|
|